Wealth Preservation Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Sell
785
-735
-48% -$163K 0.14% 74
2025
Q4
$347K Buy
1,520
+80
+6% +$18.2K 0.17% 62
2025
Q3
$333K Buy
1,440
+709
+97% +$144K 0.19% 59
2025
Q2
$136K Buy
731
+230
+46% +$42.7K 0.08% 109
2025
Q1
$105K Buy
+501
New +$97.4K 0.08% 117

Other funds holding ABBV

Wealth Preservation Advisors's ABBV Position: Q1 2026 in Review

Wealth Preservation Advisors reduced its AbbVie (ABBV) stake by 48% in Q1 2026, selling an estimated $163K and leaving 785 shares worth $171K. The position accounts for 0.14% of the portfolio, ranked #74.

Wealth Preservation Advisors first reported a position in ABBV in Q1 2025 and has held it in 5 quarters since. The position peaked at $347K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wealth Preservation Advisors held 785 shares of AbbVie worth $171K as of Q1 2026.
  • Wealth Preservation Advisors sold 735 AbbVie shares in Q1 2026, an estimated $163K.
  • AbbVie made up 0.14% of Wealth Preservation Advisors's portfolio in Q1 2026, its #74 holding.
  • Wealth Preservation Advisors first reported a position in AbbVie in Q1 2025 and has held it in 5 quarters since.
  • Wealth Preservation Advisors's AbbVie position peaked at $347K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.